AAS
BSX icon

Avantax Advisory Services’s Boston Scientific BSX Stock Holding History

Avantax Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$5.34M Buy
49,719
+7,103
+17% +$719K 0.03% 433
2025
Q1 		$4.3M Buy
42,616
+6,200
+17% +$624K 0.03% 464
2024
Q4 		$3.25M Buy
36,416
+7,282
+25% +$641K 0.02% 531
2024
Q3 		$2.44M Sell
29,134
-3,714
-11% -$293K 0.02% 608
2024
Q2 		$2.53M Buy
32,848
+17,583
+115% +$1.29M 0.02% 580
2024
Q1 		$1.05M Buy
15,265
+129
+0.9% +$8.29K 0.01% 728
2023
Q4 		$875K Sell
15,136
-830
-5% -$44.3K 0.01% 762
2023
Q3 		$843K Sell
15,966
-3,797
-19% -$199K 0.01% 749
2023
Q2 		$1.07M Buy
19,763
+1,201
+6% +$62.7K 0.01% 657
2023
Q1 		$929K Buy
18,562
+118
+0.6% +$5.56K 0.01% 684
2022
Q4 		$853K Buy
18,444
+2,803
+18% +$121K 0.01% 682
2022
Q3 		$606K Buy
15,641
+2,490
+19% +$99.9K 0.01% 699
2022
Q2 		$490K Buy
13,151
+323
+3% +$13.1K 0.01% 789
2022
Q1 		$567K Sell
12,828
-1,949
-13% -$84.5K 0.01% 741
2021
Q4 		$628K Buy
14,777
+31
+0.2% +$1.3K 0.01% 682
2021
Q3 		$645K Buy
14,746
+722
+5% +$31.9K 0.01% 622
2021
Q2 		$601K Buy
14,024
+196
+1% +$8.25K 0.01% 635
2021
Q1 		$538K Buy
13,828
+371
+3% +$14K 0.01% 597
2020
Q4 		$484K Sell
13,457
-3,437
-20% -$124K 0.01% 565
2020
Q3 		$649K Buy
16,894
+2,454
+17% +$94.6K 0.01% 705
2020
Q2 		$508K Buy
14,440
+1,929
+15% +$69.5K 0.01% 479
2020
Q1 		$411K Buy
12,511
+5,638
+82% +$220K 0.01% 485
2019
Q4 		$312K Buy
+6,873
New +$288K 0.01% 613
2019
Q3 		– Sell
-5,330
Closed -$229K – 573
2019
Q2 		$229K Buy
+5,330
New +$205K 0.01% 453

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Avantax Advisory Services's BSX Position: Q2 2025 in Review

Avantax Advisory Services increased its Boston Scientific (BSX) stake by 17% in Q2 2025, buying an estimated $719K and bringing the position to 49,719 shares worth $5.34M. The position accounts for 0.03% of the portfolio, ranked #433.

Avantax Advisory Services first reported a position in BSX in Q2 2019 and has held it in 24 quarters since. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Avantax Advisory Services held 49,719 shares of Boston Scientific worth $5.34M as of Q2 2025.
  • Avantax Advisory Services bought 7,103 Boston Scientific shares in Q2 2025, an estimated $719K.
  • Boston Scientific made up 0.03% of Avantax Advisory Services's portfolio in Q2 2025, its #433 holding.
  • Avantax Advisory Services first reported a position in Boston Scientific in Q2 2019 and has held it in 24 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.